Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 18

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 18
---
 From 2012 to 2015, Mr. Ball was Vice President for Global Quality at Ikaria, Inc., which is now a part of Mallinckrodt Pharmaceuticals. From 2008 to 2012, he was Vice President for Quality Operations at Boehringer Ingelheim, a pharmaceutical company. Mr. Ball is a trained biologist, with an M.B.A. from Westminster College, an M.Sc. in cell biology from the University of North Carolina at Charlotte, and a B.Sc. in biology from Central Michigan University.

David Dornan, Ph.D., has served as our Chief Scientific Officer since February 2025. Prior to joining us, Dr. Dornan served as Chief Scientific Officer of Elevation Oncology, Inc., an oncology company, from March 2022 until February 2025. From January 2021 to March 2022, Dr. Dornan served as Chief Scientific Officer at Bolt Biotherapeutics, Inc., a biotechnology company. From November 2017 to January 2021, Dr. Dornan served as Senior Vice President of Research and Manufacturing at Bolt Biotherapeutics. From 2012 to November 2017, Dr. Dornan held various positions at Gilead Sciences, Inc., a biopharma company, including Director and Head of Oncology Research and Senior Research Scientist II, Oncology. From 2002 to 2012, Dr. Dornan held various positions at Genentech, Inc., a biotechnology company. Dr. Dornan currently serves on the board of directors of ReviR Therapeutics, a biotechnology company. Dr. Dornan received a B.Sc. in Biochemistry and Molecular Biology from the University of Strathclyde and a Ph.D. in Molecular Oncology/Biochemistry from the University of Dundee.

There are no material legal proceedings to which any of our executive officers is a party adverse to us or any of our subsidiaries or in which any such person has a material interest adverse to us or our subsidiaries.

<div align='center'>10</div>

### CORPORATE GOVERNANCE

#### Board Composition and Structure
Our Amended and Restated Certificate of Incorporation ("Certificate of Incorporation") provides that the number of directors that constitutes the entire Board shall be fixed only by resolution of the Board acting pursuant to a resolution adopted by a majority of the whole board. Each director holds office until the expiration of the term for which they are elected and until such